Pinkawa, Michael http://orcid.org/0000-0002-6450-297X
Aebersold, Daniel M.
Böhmer, Dirk
Flentje, Michael
Ghadjar, Pirus
Schmidt-Hegemann, Nina-Sophie
Höcht, Stefan
Hölscher, Tobias
Müller, Arndt-Christian
Niehoff, Peter
Sedlmayer, Felix
Wolf, Frank
Zamboglou, Constantinos
Zips, Daniel
Wiegel, Thomas
Funding for this research was provided by:
Universitätsklinikum RWTH Aachen
Article History
Received: 17 March 2021
Accepted: 23 March 2021
First Online: 29 April 2021
Declarations
:
: M. Pinkawa, D. M. Aebersold, D. Böhmer, M. Flentje, U. Ghadjar, N.-S. Schmidt-Hegemann, S. Höcht, P. Niehoff, F. Sedlmayer, F. Wolf, C. Zamboglou, and T. Wiegel declare that they have no competing interests. A.-C. Müller and D. Zips mention the cooperation with Siemens Healthcare, Philips, and Elekta in a research project. T. Hölscher is principal investigator of two clinical trials in SABR of metastatic prostate cancer (NCT02264379, NCT04141709).
: This article does not contain any studies with human participants or animals performed by any of the authors.